Breaking News Instant updates and real-time market news.

TJX

TJX

$84.66

-0.15 (-0.18%)

, AZO

AutoZone

$665.68

13.03 (2.00%)

20:25
05/21/18
05/21
20:25
05/21/18
20:25

Notable companies reporting before tomorrow's open

Notable companies reporting before tomorrow's open, with earnings consensus, include TJX (TJX), consensus $1.02... AutoZone (AZO), consensus $13.01... Kohl's (KSS), consensus 50c... Advance Auto Parts (AAP), consensus $1.97... Eaton Vance (EV), consensus 79c... Toll Brothers (TOL), consensus 76c... International Game Technology (IGT), consensus 27c.

TJX

TJX

$84.66

-0.15 (-0.18%)

AZO

AutoZone

$665.68

13.03 (2.00%)

KSS

Kohl's

$65.47

1.79 (2.81%)

AAP

Advance Auto Parts

$119.18

0.93 (0.79%)

EV

Eaton Vance

$58.05

0.52 (0.90%)

TOL

Toll Brothers

$43.60

0.43 (1.00%)

IGT

International Game

$29.75

-0.655 (-2.15%)

  • 22

    May

  • 22

    May

  • 22

    May

  • 22

    May

  • 22

    May

  • 24

    May

  • 23

    May

TJX TJX
$84.66

-0.15 (-0.18%)

05/08/18
OTRG
05/08/18
INITIATION
OTRG
Positive
TJX initiated with a Positive at OTR Global
04/30/18
DBAB
04/30/18
INITIATION
Target $98
DBAB
Buy
TJX assumed with a Buy at Deutsche Bank
Deutsche Bank analyst Paul Trussell assumed coverage of TJX with a Buy rating and raised his firm's price target for the shares to $98 from $95.
03/12/18
FBCO
03/12/18
INITIATION
Target $85
FBCO
Neutral
TJX initiated with a Neutral at Credit Suisse
Credit Suisse initiated TJX with a Neutral and $85 price target.
03/08/18
LOOP
03/08/18
INITIATION
Target $84
LOOP
Hold
TJX initiated with a Hold at Loop Capital
Loop Capital analyst Laura Champine started TJX with a Hold rating and $84 price target, contending that the company's FY19 EPS guidance, when tax reform is excluded, reflects a "less than heroic performance in a healthy environment for retail sales and the off-price industry."
AZO AutoZone
$665.68

13.03 (2.00%)

04/23/18
WELS
04/23/18
INITIATION
Target $700
WELS
Outperform
AutoZone initiated with an Outperform at Wells Fargo
Wells Fargo analyst Zachary Fadem initiated AutoZone with an Outperform and $700 price target.
05/07/18
GSCO
05/07/18
UPGRADE
GSCO
Conviction Buy
AutoZone upgraded to Conviction Buy from Buy at Goldman Sachs
Goldman Sachs analyst Matthew Fassler added AutoZone to the Conviction Buy List with a $780 price target citing potential catalysts from May and August earnings reports. Fassler expects the more normative winter of 2017-18 to result in a solid summer season.
05/07/18
05/07/18
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. McDonald's (MCD) and AutoZone (AZO) were upgraded to Conviction Buy from Buy at Goldman Sachs. 2. Eaton (ETN), Deere (DE), and Terex (TEX) were upgraded to Outperform from In Line at Evercore ISI. 3. LendingTree (TREE) and Santander Consumer (SC) were upgraded to Buy from Neutral at UBS, while Discover (DFS) was upgraded to Neutral from Sell. 4. First Industrial Realty (FR) upgraded to Buy from Neutral at Mizuho with analyst Richard Anderson saying he sees a "path for outperformance from here" with the valuation at "floor" levels. 5. Illumina (ILMN) upgraded to Overweight from Equal Weight at Barclays with analyst Jack Meehan saying he believes his firm's NovaSeq customer survey indicates "substantial elasticity of demand." This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
04/23/18
WELS
04/23/18
INITIATION
Target $205
WELS
Outperform
Home improvement and autopart retail offers favorable pockets, says Wells Fargo
As reported earlier, Wells Fargo analyst Zachary Fadem initiated select names within the home improvement, auto part retail, home furnishings, and specialty hardlines. The analyst notes that the pullback in some of these stocks related to "uncertainty around margins, global trade policy, and the sustainability of recently improving results", which replaced the enthusiasm from the anticipated consumer strength, rising wages, and tax reform benefits earlier this year, has produced some "compelling" long-term investment opportunities. Fadem initiated Home Depot (HD) and Lowe's (LOW) at Outperform with respective price targets of $205 and $100, saying home improvement is particularly attractive in retail today given the valuations in housing and demographics tailwinds. The analyst adds that the home improvement category has seen the most consistent growth in "consumer share of wallet" to 7.5% over the past 5 years, even though that level is still below 8.7% prior peak in 2005. Fadem's view on Bed Bath and Beyond (BBBY) is less upbeat with an Underperform rating and a $16 price target based on its limited growth opportunity, margin profile, differentiation, and e-commerce strategy. Similarly, the analyst profiles the auto parts retail offering some opportunity in terms of "lost share of wallet" sliding to 1.8%, below the 10-year average of 1.9%, while offering "attractive valuations" and an opportunity to regain its footing. Fadem initiates O'Reilly (ORLY) and AutoZone (AZO) with an Outperform rating and price targets of $260 and $700 respectively, adding that these two companies exceeded the industry growth even as auto parts retailers as a group trade at a 23% discount relative to the S&P500. The analyst also initiated select names in the Home Furnishings/Specialty categories, including At Home (HOME) at Outperform with a price target of $42, Tractor Supply (TSCO) at Outperform with a price target of $70, and National Vision (EYE) with an Outperform and a price target of $40. Fadem. All of these names earned a positive view based on the analysts Growth Opportunity and Concept Differentiation screens, with the last two also cited for their potential for near term improvement.
KSS Kohl's
$65.47

1.79 (2.81%)

05/11/18
05/11/18
DOWNGRADE

Neutral
Kohl's downgraded to Neutral from Outperform at Credit Suisse
As previously reported, Credit Suisse analyst Michael Binetti downgraded Kohl's to Neutral from Outperform and lowered his price target to $64 from $72 on the company's shares. Binetti sees Q1 same store sales risk due to cold weather damaging industry traffic and Kohl's being more weather sensitive than its peers, and slightly lowered his Q1 EPS estimate on the stock. He concluded that the current risk/reward in the stock leaves him Neutral.
05/11/18
05/11/18
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Kohl's (KSS) downgraded to Neutral from Outperform at Credit Suisse with analyst Michael Binetti saying he sees first quarter same store sales risk due to cold weather damaging industry traffic and Kohl's being more weather sensitive than its peers, and slightly lowered his Q1 EPS estimate on the stock. 2. Symantec (SYMC) downgraded to Sell from Neutral at MoffettNathanson, to Equal Weight from Overweight at Barclays and First Analysis, to Perform from Outperform at Oppenheimer, and to Neutral from Buy at BTIG, to Neutral from Outperform at Macquarie, and to Neutral from Overweight at Piper Jaffray. 3. AMC Networks (AMCX) downgraded to In Line on valuation at Evercore ISI with analyst David Joyce citing valuation. 4. L Brands (LB) downgraded to Neutral from Overweight at Atlantic Equities. 5. Presidio (PSDO) downgraded to Sector Perform from Outperform at RBC Capital and to Market Perform from Outperform at Wells Fargo. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
05/15/18
MKMP
05/15/18
NO CHANGE
Target $67
MKMP
Neutral
Kohl's Q1 may see 'significant slowdown' from Q4 on weather, says MKM Partners
MKM Partners analyst Patrick McKeever keeps his Neutral rating and $67 price target on Kohl's ahead of its Q1 earnings next week, saying the quarter is facing a risk of a slowdown from Q4 activity because of the wintery weather in the East. The analyst adds that he sees SSS rising 3% in Q1, but also expects them to decelerate in the coming quarters as comparisons become "progressively more difficult", while the partnership between Kohl's and Amazon (AMZN) remains limited.
05/16/18
JEFF
05/16/18
NO CHANGE
Target $30
JEFF
Hold
Jefferies ups Macy's target to $30, says read-through positive for retail peers
Jefferies analyst Randal Konik said he liked Macy's (M) "robust" revenue growth, clean inventories and controlled markdowns in the first quarter, though he also noted that Q2 comparable sales are expected to be down given the Friends and Family shift that aided Q1. Following the earnings report, Konik raised his price target on Macy's shares to $30 from $27, but he keeps a Hold rating on the stock, citing secular pressures impacting the company and the industry. The analyst, who thinks Macy's report has a positive read-through for retail more broadly, continues to prefer Kohl's (KSS), citing its off-mall positioning, differentiated assortment, and "omni-channel leadership."
AAP Advance Auto Parts
$119.18

0.93 (0.79%)

04/23/18
WELS
04/23/18
INITIATION
Target $110
WELS
Market Perform
Advance Auto Parts initiated with a Market Perform at Wells Fargo
Wells Fargo analyst Zachary Fadem started Advance Auto Parts with a Market Perform rating and $110 price target.
05/08/18
05/08/18
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Advance Auto Parts (AAP) upgraded to Overweight from Neutral at Atlantic Equities with analyst Sam Hudson saying he expects an inflection in comps and margins when the company reports towards the end of May. 2. Northrop Grumman (NOC) and Harris (HRS) were upgraded to Conviction Buy from Buy at Goldman Sachs. 3. Louisiana-Pacific (LPX) upgraded to Buy from Neutral at DA Davidson with analyst Steven Chercover saying while the oriented strand board prices are near or at their peak, the company's blend of earnings power, balance sheet liquidity, and sales mix offer a "compelling value" at the stock's current price level. 4. Columbia Property (CXP) upgraded to Buy from Neutral at Goldman Sachs with analyst Andrew Rosivach saying he sees an attractive entry point at current share levels. 5. Loma Negra (LOMA) upgraded to Buy from Hold at HSBC and to Overweight from Equal Weight at Morgan Stanley. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
05/08/18
ATLE
05/08/18
UPGRADE
Target $140
ATLE
Overweight
Advance Auto Parts upgraded to Overweight at Atlantic Equities
As previously reported, Atlantic Equities upgraded Advanced Auto Parts to Overweight from Neutral with a $140 price target. Analyst Sam Hudson expects an inflection in comps and margins when the company reports towards the end of May. Hudson notes industry fundamentals are improving and Advance Auto should benefit from favorable weather in the Northeast.
05/08/18
ATLE
05/08/18
UPGRADE
ATLE
Overweight
Advance Auto Parts upgraded to Overweight from Neutral at Atlantic Equities
EV Eaton Vance
$58.05

0.52 (0.90%)

05/02/18
05/02/18
UPGRADE
Target $63

Buy
Eaton Vance upgraded to Buy on growth potential at BofA/Merrill
As previously reported, BofA/Merrill upgraded Eaton Vance to Buy and raised its price target to $63 from $61. Analyst Michael Carrier believes Eaton Vance is poised to deliver "superior organic growth" in a rising rate environment and expects margins to rise from attractive product mix. Further, the analyst sees meaningful potential in Calvert, ample room for growth internationally, and views valuation as attractive.
05/02/18
BOFA
05/02/18
UPGRADE
BOFA
Buy
Eaton Vance upgraded to Buy from Neutral at BofA/Merrill
10/17/17
DBAB
10/17/17
INITIATION
Target $57
DBAB
Buy
Eaton Vance initiated with a Buy at Deutsche Bank
Deutsche Bank analyst Brian Bedell started Eaton Vance with a Buy rating and $57 price target.
08/24/17
08/24/17
UPGRADE
Target $48

Neutral
Eaton Vance upgraded to Neutral on sustainable flow trends at JPMorgan
As previously reported, JPMorgan analyst Kenneth Worthington upgraded Eaton Vance to Neutral from Underweight, stating that he believes the company's recent positive flow trends can continue. He thinks strong organic AUM growth can persist and support margin expansion, he tells investors. Worthington has a $48 price target on Eaton Vance shares.
TOL Toll Brothers
$43.60

0.43 (1.00%)

05/17/18
MKMP
05/17/18
NO CHANGE
Target $60
MKMP
Buy
Toll Brothers can perform in environment of rising rates, says MKM Partners
MKM Partners analyst Megan McGrath kept her Buy rating and $60 price target on Toll Brothers ahead of its earnings next week. The analyst says that the stock price is down about 15% year-to-date as fears of rising interest rates and higher input costs "offset solid earnings and macro results". McGrath contends however that the stock can perform well in a "steadily rising rate environment", adding that another quarter showing solid order growth and stable margins could reassure investors that the housing market is healthy.
01/22/18
FBCO
01/22/18
NO CHANGE
Target $56
FBCO
Neutral
Toll Brothers price target raised to $56 from $45 at Credit Suisse
Credit Suisse analyst Susan Maklari raised her price target for Toll Brothers to $56 from $45 on valuation and tax reform. The analyst reiterates a Neutral rating on the shares.
12/29/17
WEDB
12/29/17
NO CHANGE
WEDB
Wedbush raises homebuilder price targets due to new tax bill
Wedbush analyst Jay McCanless increased his price targets on homebuilders by an average of 13.6% to reflect the potential impacts from the new tax bill, though he noted that his estimates and targets could need to be adjusted as companies begin reporting earnings giving specific tax guidance. He made the largest target increases to PulteGroup (PHM), Century Communities (CCS) and Taylor Morrison (TMHC), he noted. Other publicly traded companies in the space include Beazer Homes (BZH), CalAtlantic (CAA), D.R. Horton (DHI), Hovnanian (HOV), KB Home (KBH), Lennar (LEN), M.D.C. Holdings (MDC) and Toll Brothers (TOL).
12/20/17
ARGS
12/20/17
NO CHANGE
Target $55
ARGS
Buy
Toll Brothers price target raised to $55 from $45 at Argus
Argus analyst Christopher Graja remains upbeat on the housing recovery and on Toll Brothers' leading position in the luxury market, stating that he does not see the reduced threshold for mortgage deductibility in the new tax code as particularly concerning. He raised his price target on Toll shares to $55 from $45 and keeps a Buy rating on the stock.
IGT International Game
$29.75

-0.655 (-2.15%)

05/15/18
BOFA
05/15/18
NO CHANGE
BOFA
Supreme Court ruling on sports betting positive for regionals, game tech, says BofA/Merrill
BofA/Merrill analyst Shaun Kelley notes that the Supreme Court ruled 6-3 to repeal the Professional and Amateur Sports Protection Act, which had effectively banned full sports betting in every state except Nevada. While the analyst expects operator margins to be low, he sees upside for all of regional gaming, while gaming tech could be a key beneficiary. Reflecting sports betting in higher multiples, Kelley raised his price targets for Boyd Gaming (BYD) to $45 from $42, Penn National (PENN) to $36 from $32, Scientific Games (SGMS) to $70 from $60, and International Game (IGT) to $36 from $34.
05/14/18
JEFF
05/14/18
NO CHANGE
JEFF
Jefferies says Penn National, Caesars among winners from sports gaming ruling
After the Supreme Court ruled that the PASPA provision prohibiting state authorization of organized sports gambling violates the tenth amendment, Jefferies analyst David Katz reiterated his view on which companies are positioned to be key beneficiaries of the decision. He continues to identify Penn National (PENN) and Caesars (CSR) as among the top winners in terms of casino operators, followed by Eldorado Resorts (ERI), Churchill Downs (CHDN), Boyd Gaming (BYD), Monarch Casino (MCRI), and MGM Resorts (MGM). He also sees "location-agnostic" suppliers Scientific Games (SGMS) and International Game (IGT) as winners, Katz tells investors.
02/20/18
JEFF
02/20/18
INITIATION
Target $33
JEFF
Buy
International Game initiated with a Buy at Jefferies
Jefferies analyst David Katz started International Game Technology with a Buy rating and $33 price target. The analyst views the story as a combination of the slot business turnaround and a stable lottery business.
12/04/17
DBAB
12/04/17
NO CHANGE
Target $34
DBAB
Buy
International Game joint venture news a positive, says Deutsche Bank
Deutsche Bank analyst Carlo Santarelli says International Game Technology and its joint venture partners officially accepting the renewal of the Italian Scratch & Win concession through September 2028 is positive news. The development removes a potential 2018 overhang while the terms of the existing contract were left as is, Santarelli tells investors in a research note. He keeps a Buy rating on International Game with a $34 price target.

TODAY'S FREE FLY STORIES

OHI

Omega Healthcare

$31.86

0.07 (0.22%)

21:21
06/24/18
06/24
21:21
06/24/18
21:21
Downgrade
Omega Healthcare rating change at Wells Fargo »

Omega Healthcare…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MDT

Medtronic

$86.80

0.51 (0.59%)

20:05
06/24/18
06/24
20:05
06/24/18
20:05
Hot Stocks
MiniMed 670G system real-world data show improved time in range »

Medtronic announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jun

  • 25

    Jun

  • 26

    Jun

  • 12

    Jul

GE

General Electric

$13.05

0.29 (2.27%)

, AMZN

Amazon.com

$1,715.07

-15.13 (-0.87%)

19:31
06/24/18
06/24
19:31
06/24/18
19:31
Hot Stocks
On The Fly: Top five weekend stock stories »

Catch up on the…

GE

General Electric

$13.05

0.29 (2.27%)

AMZN

Amazon.com

$1,715.07

-15.13 (-0.87%)

BRK.A

Berkshire Hathaway

$286,859.95

2244.95 (0.79%)

BRK.B

Berkshire Hathaway

$188.89

0.05 (0.03%)

JPM

JPMorgan

$105.73

-1.79 (-1.66%)

CMCSA

Comcast

$33.82

1.02 (3.11%)

CMCSK

Comcast

$0.00

(0.00%)

C

Citi

$67.20

-0.43 (-0.64%)

TWTR

Twitter

$45.90

0.68 (1.50%)

MD

Mednax

$44.99

-0.11 (-0.24%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Jul

  • 26

    Jul

  • 27

    Jul

  • 12

    Oct

  • 14

    Jan

  • 15

    Apr

  • 13

    Jul

  • 15

    Oct

OGE

OGE Energy

$34.95

0.15 (0.43%)

19:25
06/24/18
06/24
19:25
06/24/18
19:25
Downgrade
OGE Energy rating change at Goldman Sachs »

OGE Energy downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TWX

Acquired by T

$0.00

(0.00%)

, CMCSA

Comcast

$33.82

1.02 (3.11%)

19:18
06/24/18
06/24
19:18
06/24/18
19:18
Hot Stocks
Box Office Battle: 'Jurassic World: Fallen Kingdom' wins weekend with $150M »

Universal (CMCSA; CMCSK)…

TWX

Acquired by T

$0.00

(0.00%)

CMCSA

Comcast

$33.82

1.02 (3.11%)

CMCSK

Comcast

$0.00

(0.00%)

SNE

Sony

$50.36

1.15 (2.34%)

FOX

21st Century Fox

$48.28

0.31 (0.65%)

FOXA

21st Century Fox

$48.59

0.25 (0.52%)

LGF.A

Lionsgate

$26.90

0.6 (2.28%)

DIS

Disney

$106.37

0.48 (0.45%)

VIAB

Viacom

$30.27

-0.13 (-0.43%)

VIA

Viacom

$35.70

0.15 (0.42%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Aug

AMZN

Amazon.com

$1,715.07

-15.13 (-0.87%)

, BRK.A

Berkshire Hathaway

$286,859.95

2244.95 (0.79%)

18:53
06/24/18
06/24
18:53
06/24/18
18:53
Periodicals
Amazon/Berkshire/JPMorgan venture takes aim at middlemen, Bloomberg says »

The health venture…

AMZN

Amazon.com

$1,715.07

-15.13 (-0.87%)

BRK.A

Berkshire Hathaway

$286,859.95

2244.95 (0.79%)

BRK.B

Berkshire Hathaway

$188.89

0.05 (0.03%)

JPM

JPMorgan

$105.73

-1.79 (-1.66%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Jul

  • 12

    Oct

GE

General Electric

$13.05

0.29 (2.27%)

18:42
06/24/18
06/24
18:42
06/24/18
18:42
Periodicals
General Electric nearing deal to sell industrial engines unit, WSJ says »

General Electric is close…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NVO

Novo Nordisk

$46.84

0.435 (0.94%)

18:25
06/24/18
06/24
18:25
06/24/18
18:25
Conference/Events
Novo Nordisk to hold an investor and analyst event »

In conjunction with the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Jun

ERYP

Erytech Pharma

$0.00

(0.00%)

18:17
06/24/18
06/24
18:17
06/24/18
18:17
Hot Stocks
Erytech Pharma confirms strategic focus of eryaspase on solid tumors »

Erytech Pharma announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LXRX

Lexicon

$13.58

0.51 (3.90%)

18:12
06/24/18
06/24
18:12
06/24/18
18:12
Hot Stocks
Lexicon announces positive 52-week results from Sotagliflozin inTandem1 study »

Lexicon Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jun

  • 22

    Mar

PODD

Insulet

$97.37

0.5697 (0.59%)

18:09
06/24/18
06/24
18:09
06/24/18
18:09
Hot Stocks
Insulet presents positive results for Omnipod Horizon Hybrid Closed-Loop System »

Insulet announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LLY

Eli Lilly

$85.90

-0.17 (-0.20%)

18:00
06/24/18
06/24
18:00
06/24/18
18:00
Hot Stocks
Real-World data show advantages in people treated with Eli Lilly's Trulicity »

People with type 2…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 10

    Sep

LXRX

Lexicon

$13.58

0.51 (3.90%)

17:56
06/24/18
06/24
17:56
06/24/18
17:56
Hot Stocks
Lexicon announces positive 52-week results from Sotagliflozin inTandem2 study »

Lexicon Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jun

  • 22

    Mar

DGX

Quest Diagnostics

$112.13

0.93 (0.84%)

17:53
06/24/18
06/24
17:53
06/24/18
17:53
Hot Stocks
Employer wellness programs may reduce risk of developing chronic conditions »

Employer wellness…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LLY

Eli Lilly

$85.90

-0.17 (-0.20%)

17:44
06/24/18
06/24
17:44
06/24/18
17:44
Hot Stocks
New data reinforce potential of Eli Lilly's Ultra Rapid Lispro in diabetes »

Eli Lilly's ultra…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 10

    Sep

LLY

Eli Lilly

$85.90

-0.17 (-0.20%)

17:38
06/24/18
06/24
17:38
06/24/18
17:38
Hot Stocks
Eli Lilly announces findings from new analyses of EMPA-REG OUTCOME trial »

Boehringer Ingelheim and…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 10

    Sep

CTRV

ContraVir Pharmaceuticals

$1.47

-0.06 (-3.92%)

17:30
06/24/18
06/24
17:30
06/24/18
17:30
Conference/Events
ContraVir Pharmaceuticals to hold a business news update conference call »

Management discusses…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ZFGN

Zafgen

$6.94

0.32 (4.83%)

17:27
06/24/18
06/24
17:27
06/24/18
17:27
Hot Stocks
Zafgen announces positive full results in phase 2 clinical trial of ZGN-1061 »

Zafgen announced positive…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MNKD

MannKind

$1.98

0.02 (1.02%)

17:22
06/24/18
06/24
17:22
06/24/18
17:22
Hot Stocks
MannKind presents positive Afrezza clinical data from STAT, AFFINITY studies »

MannKind announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MRK

Merck

$61.46

0.295 (0.48%)

16:53
06/24/18
06/24
16:53
06/24/18
16:53
Hot Stocks
Merck presents new data from comparative trials in Type 2 diabetes »

Merck, known as MSD…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Jun

  • 10

    Sep

  • 23

    Oct

NVO

Novo Nordisk

$46.84

0.435 (0.94%)

04:55
06/24/18
06/24
04:55
06/24/18
04:55
Conference/Events
Novo Nordisk to hold an investor and analyst event »

In conjunction with the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Jun

A

Agilent

$62.79

-0.24 (-0.38%)

, ABT

Abbott

$61.93

0.19 (0.31%)

04:55
06/24/18
06/24
04:55
06/24/18
04:55
Conference/Events
American Diabetes Association to hold a conference »

78th Scientific Sessions…

A

Agilent

$62.79

-0.24 (-0.38%)

ABT

Abbott

$61.93

0.19 (0.31%)

AKCA

Akcea Therapeutics

$26.24

0.4 (1.55%)

AMGN

Amgen

$184.86

-1.14 (-0.61%)

AZN

AstraZeneca

$35.06

-0.095 (-0.27%)

BAYRY

Bayer

$0.00

(0.00%)

CL

Colgate-Palmolive

$64.63

1.15 (1.81%)

DXCM

DexCom

$99.52

-0.2 (-0.20%)

LLY

Eli Lilly

$85.90

-0.17 (-0.20%)

IRWD

Ironwood

$19.35

0.74 (3.98%)

JNJ

Johnson & Johnson

$122.81

1.36 (1.12%)

MDT

Medtronic

$86.80

0.51 (0.59%)

MNKD

MannKind

$1.98

0.02 (1.02%)

WAKE

Wake Forest Bancshares Inc.

$0.00

(0.00%)

VLRX

Valeritas

$1.39

0.035 (2.58%)

TNDM

TNDM

SNY

Sanofi

$39.98

0.96 (2.46%)

SIEGY

Siemens

$0.00

(0.00%)

SENS

Senseonics

$4.76

-0.2 (-4.03%)

REGN

Regeneron

$331.82

2.81 (0.85%)

PODD

Insulet

$97.37

0.5697 (0.59%)

NVO

Novo Nordisk

$46.84

0.435 (0.94%)

MRK

Merck

$61.46

0.295 (0.48%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Jun

  • 25

    Jun

  • 25

    Jun

  • 25

    Jun

  • 25

    Jun

  • 26

    Jun

  • 28

    Jun

  • 02

    Jul

  • 06

    Jul

  • 12

    Jul

  • 17

    Jul

  • 18

    Jul

  • 11

    Aug

  • 27

    Aug

  • 30

    Aug

  • 10

    Sep

  • 06

    Oct

  • 20

    Oct

  • 23

    Oct

  • 28

    Oct

  • 28

    Jan

  • 22

    Mar

AMGN

Amgen

$184.86

-1.14 (-0.61%)

12:23
06/23/18
06/23
12:23
06/23/18
12:23
Hot Stocks
Amgen's Repatha 'significantly reduced' LDL-C, non-HDL-C in Type 2 diabetes »

Amgen announced new data…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LLY

Eli Lilly

$85.90

-0.17 (-0.20%)

12:18
06/23/18
06/23
12:18
06/23/18
12:18
Hot Stocks
Eli Lilly's Trulicity shows promise in delivering efficacy in type 2 diabetes »

Two investigational doses…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 10

    Sep

IRWD

Ironwood

$19.35

0.74 (3.98%)

12:14
06/23/18
06/23
12:14
06/23/18
12:14
Hot Stocks
Ironwood announced Praliciguat phase IIa study data »

Ironwood Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jun

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.